These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3743429)

  • 21. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man.
    Caldwell JH; Bush CA; Greenberger NJ
    J Clin Invest; 1971 Dec; 50(12):2638-44. PubMed ID: 5129315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Myocardium and plasma levels of amiodarone and its N-monodeethylated metabolite].
    Marchiset D; Egre A; Baille Y; Cano JP; Serradimigni A
    Therapie; 1983; 38(1):114-5. PubMed ID: 6867994
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical pharmacokinetics of amiodarone.
    Latini R; Tognoni G; Kates RE
    Clin Pharmacokinet; 1984; 9(2):136-56. PubMed ID: 6370540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
    Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
    Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue distribution of amiodarone and desethylamiodarone in rats after repeated oral administration of various amiodarone dosages.
    Plomp TA; Wiersinga WM; Maes RA
    Arzneimittelforschung; 1985; 35(12):1805-10. PubMed ID: 4096733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens.
    Brien JF; Jimmo S; Brennan FJ; Armstrong PW; Abdollah H
    Drug Metab Dispos; 1990; 18(6):846-51. PubMed ID: 1981527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Amiodarone and its infusion velocity in recent-onset atrial fibrillation].
    Ramus GV; Veglio F; Bonino ML; Tonda L
    G Ital Cardiol; 1991 Oct; 21(10):1083-91. PubMed ID: 1804746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amiodarone and desethylamiodarone concentrations in plasma and tissues of surgically treated patients on long-term oral amiodarone treatment.
    Plomp TA; Hauer RN; Robles de Medina EO
    In Vivo; 1990; 4(2):97-100. PubMed ID: 2129806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-performance liquid chromatographic isolation and fast atom bombardment mass spectrometric identification of Di-N-desethylamiodarone, a new metabolite of amiodarone in the dog.
    Latini R; Reginato R; Burlingame AL; Kates RE
    Biomed Mass Spectrom; 1984 Sep; 11(9):466-71. PubMed ID: 6509156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of phenobarbitone on the pharmacokinetics and tissue levels of amiodarone in the rat.
    Fruncillo RJ; Bernhard R; Swanson BN; Vlasses PH; Ferguson RK
    J Pharm Pharmacol; 1985 Oct; 37(10):729-31. PubMed ID: 2867144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amiodarone in patients on long-term dialysis.
    Bonati M; Galletti F; Volpi A; Cumetti C; Rumolo R; Bassini O; Tognoni G
    N Engl J Med; 1983 Apr; 308(15):906. PubMed ID: 6835293
    [No Abstract]   [Full Text] [Related]  

  • 32. Amiodarone: individualizing dosage with serum concentrations.
    Rotmensch HH; Swanson BN; Greenspon AJ; Shoshani D; Greenspan AM
    Pacing Clin Electrophysiol; 1983 Nov; 6(6):1327-35. PubMed ID: 6196742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of amiodarone, desethylamiodarone and other iodine-containing amiodarone metabolites.
    Stäubli M; Troendle A; Schmid B; Balmer P; Kohler B; Studer H; Bircher J
    Eur J Clin Pharmacol; 1985; 29(4):417-23. PubMed ID: 4092724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum and myocardial kinetics of amiodarone and its deethyl metabolite after intravenous administration in rabbits.
    Kannan R; Ikeda N; Wagner R; Drachenberg M; Singh BN
    J Pharm Sci; 1984 Sep; 73(9):1208-11. PubMed ID: 6491937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of amiodarone after intravenous and oral administration.
    Andreasen F; Agerbaek H; Bjerregaard P; Gøtzsche H
    Eur J Clin Pharmacol; 1981 Mar; 19(4):293-9. PubMed ID: 7286032
    [No Abstract]   [Full Text] [Related]  

  • 36. Renal elimination of amiodarone and its desethyl metabolite.
    Harris L; Hind CR; McKenna WJ; Savage C; Krikler SJ; Storey GC; Holt DW
    Postgrad Med J; 1983 Jul; 59(693):440-2. PubMed ID: 6622326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absolute bioavailability of amiodarone in normal subjects.
    Pourbaix S; Berger Y; Desager JP; Pacco M; Harvengt C
    Clin Pharmacol Ther; 1985 Feb; 37(2):118-23. PubMed ID: 3967454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity.
    Stäubli M; Bircher J; Galeazzi RL; Remund H; Studer H
    Eur J Clin Pharmacol; 1983; 24(4):485-94. PubMed ID: 6861863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of amiodarone in man.
    Riva E; Gerna M; Latini R; Giani P; Volpi A; Maggioni A
    J Cardiovasc Pharmacol; 1982; 4(2):264-9. PubMed ID: 6175810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amiodarone and desethylamiodarone distribution in the atrium and adipose tissue of patients undergoing short- and long-term treatment with amiodarone.
    Barbieri E; Conti F; Zampieri P; Trevi GP; Zardini P; d'Aranno V; Latini R
    J Am Coll Cardiol; 1986 Jul; 8(1):210-3. PubMed ID: 3711518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.